Search Results - "Baak, Jan P A"

Major bioactive chemical compounds in Astragali Radix samples from different vendors vary greatly by Kafle, Bijay, Baak, Jan P. A, Brede, Cato

“…The worldwide traditional Chinese medicine (TCM) herbs sales figures have increased considerably to 50 billion US$ (2018). Astragali Radix (AR) is amongst the…”
Get full text

Proliferation and immunohistochemistry for p53, CD25 and CK20 in predicting prognosis of non-muscle invasive papillary urothelial carcinomas by Kvikstad, Vebjørn, Lillesand, Melinda, Gudlaugsson, Einar, Mangrud, Ok Målfrid, Rewcastle, Emma, Skaland, Ivar, Baak, Jan P A, Janssen, Emiel A M

“…Non-muscle invasive papillary urothelial carcinoma is a prevalent disease with a high recurrence tendency. Good prognostic and reproducible biomarkers for…”
Get full text

Supersaturation and Precipitation Applicated in Drug Delivery Systems: Development Strategies and Evaluation Approaches by Gan, Yanxiong, Baak, Jan P A, Chen, Taijun, Ye, Hua, Liao, Wan, Lv, Huixia, Wen, Chuanbiao, Zheng, Shichao

“…Supersaturation is a promising strategy to improve gastrointestinal absorption of poorly water-soluble drugs. Supersaturation is a metastable state and…”
Get full text

Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer by Gudlaugsson, Einar, Skaland, Ivar, Janssen, Emiel A M, Smaaland, Rune, Shao, Zhiming, Malpica, Anais, Voorhorst, Feja, Baak, Jan P A

“…Gudlaugsson E, Skaland I, Janssen E A M, Smaaland R, Shao Z, Malpica A, Voorhorst F & Baak J P A 
(2012) Histopathology
Comparison of the effect of different…”
Get full text

Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer by Lillesand, Melinda, Kvikstad, Vebjørn, Mangrud, Ok Målfrid, Gudlaugsson, Einar, van Diermen-Hidle, Bianca, Skaland, Ivar, Baak, Jan P. A, Janssen, Emiel A. M

“…In urothelial cell type non-muscle invasive urinary bladder carcinoma, TNM stage and WHO grade are widely used to classify patients into low and high-risk…”
Get full text

MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers by Egeland, Nina Gran, Jonsdottir, Kristin, Aure, Miriam Ragle, Sahlberg, Kristine, Kristensen, Vessela N, Cronin-Fenton, Deirdre, Skaland, Ivar, Gudlaugsson, Einar, Baak, Jan P A, Janssen, Emiel A M

“…Previously, we have shown that miR-18a and miR-18b gene expression strongly correlates with high proliferation, oestrogen receptor -negativity (ER ),…”
Get full text

Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers by Jonsdottir, Kristin, Janssen, Susanne R, Da Rosa, Fabiana C, Gudlaugsson, Einar, Skaland, Ivar, Baak, Jan P A, Janssen, Emiel A M

“…Although lymph node negative (LN-) breast cancer patients have a good 10-years survival (∼85%), most of them still receive adjuvant therapy, while only some…”
Get full text

Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients by Egeland, Nina Gran, Austdal, Marie, van Diermen-Hidle, Bianca, Rewcastle, Emma, Gudlaugsson, Einar G, Baak, Jan P A, Skaland, Ivar, Janssen, Emiel A M, Jonsdottir, Kristin

“…Protein expression of Myristoylated alanine-rich C kinase substrate like-1 (MARCKSL1) has been identified as a prognostic factor in lymph-node negative (LN-)…”
Get full text

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study by Lende, Tone Hoel, Austdal, Marie, Bathen, Tone Frost, Varhaugvik, Anne Elin, Skaland, Ivar, Gudlaugsson, Einar, Egeland, Nina G, Lunde, Siri, Akslen, Lars A, Jonsdottir, Kristin, Janssen, Emiel A M, Søiland, Håvard, Baak, Jan P A

“…The metabolic consequences of preoperative carbohydrate load in breast cancer patients are not known. The present explorative study investigated the systemic…”
Get full text

Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder by Mangrud, Ok Målfrid, Waalen, Rune, Gudlaugsson, Einar, Dalen, Ingvild, Tasdemir, Ilker, Janssen, Emiel A M, Baak, Jan P A

“…European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highly on stage and WHO1973-grade but grading reproducibility is wanting…”
Get full text

Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas by Kvikstad, Vebjørn, Mangrud, Ok Målfrid, Gudlaugsson, Einar, Dalen, Ingvild, Espeland, Hans, Baak, Jan P A, Janssen, Emiel A M

“…European treatment guidelines for pTa and pT1 urinary bladder urothelial carcinoma depend highly on stage and WHO-grade. Both the WHO73 and the WHO04 grading…”
Get full text

Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade? by Feng, Weiwei, Malpica, Anais, Skaland, Ivar, Gudlaugsson, Einar, Robboy, Stanley J, Dalen, Ingvild, Hua, Keqin, Zhou, Xianrong, Baak, Jan P A

“…An estimated 1500-3000 invasive Endometrial Stromal Sarcomas (ESS) cases annually occur worldwide. Before 2003, ESS was divided as low and high grade ESS based…”
Get full text

Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer by Jonsdottir, Kristin, Assmus, Jörg, Slewa, Aida, Gudlaugsson, Einar, Skaland, Ivar, Baak, Jan P A, Janssen, Emiel A M

“…The overall survival rate is good for lymph-node-negative breast cancer patients, but they still suffer from serious over- and some undertreatments. Prognostic…”
Get full text

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers by Baak, Jan P. A, Gudlaugsson, Einar, Skaland, Ivar, Guo, Lydia Hui Ru, Klos, Jan, Lende, Tone Hoel, Søiland, Håvard, Janssen, Emiel A. M, zur Hausen, Axel

“…Independent studies have shown that in node negative breast cancer patients less than 71 years, the proliferation marker mitotic activity index (MAI) is the…”
Get full text

Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age by Skaland, Ivar, Janssen, Emiel A. M, Gudlaugsson, Einar, Klos, Jan, Kjellevold, Kjell H, Søiland, Håvard, Baak, Jan P. A

“…We validated and compared the prognostic value of the proliferation marker phosphohistone H3 (PPH3) with classical variables in 241 T₁₋₂N₀M₀ breast cancer…”
Get full text

The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer by Jonsdottir, Kristin, Zhang, Hui, Jhagroe, Darshni, Skaland, Ivar, Slewa, Aida, Björkblom, Benny, Coffey, Eleanor T., Gudlaugsson, Einar, Smaaland, Rune, Janssen, Emiel A. M., Baak, Jan P. A.

“…There is a need for new biomarkers to more correctly identify node-negative breast cancer patients with a good or bad prognosis. Myristoylated alanine-rich C…”
Get full text

Consistent condom use increases the regression rate of cervical intraepithelial neoplasia 2-3 by Munk, Ane Cecilie, Gudlaugsson, Einar, Malpica, Anais, Fiane, Bent, Løvslett, Kjell I, Kruse, Arnold-Jan, Øvestad, Irene Tveiterås, Voorhorst, Feja, Janssen, Emiel A M, Baak, Jan P A

“…Cervical intraepithelial neoplasia grades 2-3 (CIN2-3) are usually treated by cone excision, although only 30% progress to cancer and 6-50% regress…”
Get full text

Clinical and Biological Interpretation of Survival Curves of Cancer Patients, Exemplified With Stage IV Non-Small Cell Lung Cancers With Long Follow-up by Baak, Jan P A, Li, Hegen, Guo, Huiru

“…Worldwide, 18.1 million new invasive cancers and 9.9 million cancer deaths occurred in 2020. Lung cancer is the second most frequent (11.4%) and, with 1.8…”
Get full text

"How Long Have I Got?" in Stage IV NSCLC Patients With at Least 3 Months Up to 10 Years Survival, Accuracy of Long-, Intermediate-, and Short-Term Survival Prediction Is Not Good Enough to Answer This Question by Guo, Huiru, Li, Hegen, Zhu, Lihua, Feng, Jiali, Huang, Xiange, Baak, Jan P A

“…Most lung cancer patients worldwide [stage IV nonsmall cell lung cancer (NSCLC)] have a poor survival: 25%-30% die <3 months. Yet, of those surviving…”
Get full text

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial by Lende, Tone Hoel, Austdal, Marie, Varhaugvik, Anne Elin, Skaland, Ivar, Gudlaugsson, Einar, Kvaløy, Jan Terje, Akslen, Lars A, Søiland, Håvard, Janssen, Emiel A M, Baak, Jan P A

“…Conflicting results have been reported on the influence of carbohydrates in breast cancer. To determine the influence of pre-operative per-oral carbohydrate…”
Get full text